STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

KMDA KAMADA LIMITED StockScouter® Report

8

StockScouter® Score

KAMADA LIMITED, a small cap growth company in the healthcare sector, is expected to outperform the market over the next six months with less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
  • Short-term relative price momentum exhibits meaningful strength. Postive
  • Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a small company like KMDA

 

Concerns

  • Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, growth stocks will be neutral, and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 20% done.
Progress: 100% done.
Low
High

Core Model Grades

A
C
C
C

Previous Ratings

6
7
7